Skip to content
Screener

Pfizer PFE Cumulative Cost Basis

Cumulative Cost Basis at other companies

Amgen logo
AmgenAMGN
$13.42B+79.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ
——
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
——
Incyte logo
IncyteINCY
——
AbbVie logo
AbbVieABBV
——
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
——

Segments

By segment

See full
Biopharma$3.3B+22.2%

Other financials

Income statement

See full
Revenue$15.0B+2.6%
Gross profit$10.9B+0.6%
Net income-$248.0M-109%
EPS (diluted)-$0.04-108%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+4.9%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$149.33B+9.8%
Enterprise value$212B+9.2%
P/E16.8×—
P/S2.3×+0.2×

Profitability

See full
Gross margin73.2%+1.1pp
Net margin15.7%—
FCF margin18%+8.8pp

Returns & leverage

See full
Return on equity10.6%—
Debt / equity0.7×0.0×
Current ratio1.2×0.0×